Company news
Orion Corp. news in 2025
Orion Corp.'s news releases, calls and decks from 2025, newest first.
Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025
December 3, 2025
71,498 Orion Corporation A shares converted into B shares
November 27, 2025
Orion receives award for international growth from the President of the Republic of Finland
November 14, 2025
Orion Group Interim Report January–September 2025
October 28, 2025
49,164 Orion Corporation A shares converted into B shares
October 24, 2025
Orion and Abzena announce exclusive commercial license for Abzena’s antibody
October 23, 2025
Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025
October 14, 2025
Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal
September 30, 2025
80,802 Orion Corporation A shares converted into B shares
September 19, 2025
337,000 Orion Corporation A shares converted into B shares
August 20, 2025
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
August 8, 2025
Orion Corporation: Managers’ transactions – Satu Ahomäki
August 4, 2025
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
July 29, 2025
Darolutamide receives EU approval in third indication for patients with advanced prostate cancer
July 21, 2025
Orion Group Half-Year Financial Report January–June 2025
July 18, 2025
Orion Corporation’s financial reporting and Annual General Meeting in 2026
July 18, 2025
Inside information: Orion upgrades full-year outlook for 2025
July 9, 2025
Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025
July 4, 2025
141,959 Orion Corporation A shares converted into B shares
June 23, 2025